Home » Headlines » Currently Reading:

Morning Headlines 11/10/16

November 9, 2016 Headlines 3 Comments

Policy experts say quick repeal and replace of ACA unlikely

Health policy experts say that despite GOP control of the White House, Senate, and House of Representatives, and persistent promises from Congress to repeal or replace, a full repeal of ACA remains unlikely due to the simple fact that millions of Americans would lose their health insurance.

Cerner, HCA stocks dip with ACA uncertainty

On the stock market, healthcare stocks are slipping on uncertainty around a potential ACA repeal. Cerner stock fell 4.6 percent overnight, while HCA’s stock price fell 12.4 percent.

Kaiser Foundation Health Plan and Hospitals Report Year-to-Date and Third Quarter 2016 Financial Results

Kaiser Permanente reports Q3 results: revenue grew to $48.3 billion, resulting in $672 million in operating income, up from $363 million for the same quarter last year.

How some hospitals are replacing pricy EpiPens with a $10 version

In response to increasing EpiPen prices, the University of Utah Health Care system is replacing EpiPen’s within the system with a $10 EpiKit, which will include a vial of epinephrine, two needles, alcohol wipes, two syringes, and instructions.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there are "3 comments" on this Article:

  1. RE: EpiPens — use of these in hospitals and clinics was just good marketing and sales. A solution looking for a problem. Clinical staff at hospitals and clinics are or should be trained on how to draw and administer an injection. Even patients giving their loved one’s allergy shots at home already have the skill set to accomplish the same thing without using the expensive EpiPen. Kudos to the Utah pharmacist for seeing the light.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links